This observation in a small series of course deserves further attention in much larger patient cohorts, and supports our evidence on the impact of LFA-3/CD2 interactions between NLC and CLL cells within the TME. The gene discussed is CD2; the disease is B-cell chronic lymphocytic leukemia.